Binding Database

The following articles (labelled with PubMed ID or TBD) are for your review

PMID

Cmpds

Data

Article Title

Organization

Imidazopyridyl compounds as aldosterone synthase inhibitors.

Merck Usa

Discovery of Spirocyclic Aldosterone Synthase Inhibitors as Potential Treatments for Resistant Hypertension.

Merck Research Laboratories

Discovery of pyrimidine carboxamides as potent and selective CCK1 receptor agonists.

Merck

Identification of novel and orally active spiroindoline NPY Y5 receptor antagonists.

Tsukuba Research Institute

2-Substituted piperazine-derived imidazole carboxamides as potent and selective CCK1R agonists for the treatment of obesity.

Merck

Discovery of imidazole carboxamides as potent and selective CCK1R agonists.

Merck Research Laboratories

2-Aminoquinoline melanin-concentrating hormone (MCH)1R antagonists.

Merck Research Laboratories

4-Aminoquinoline melanin-concentrating hormone 1-receptor (MCH1R) antagonists.

Merck Research Laboratories

149

1,2-substituted cyclopentanes as orexin receptor antagonists

Takeda Pharmaceutical

Structural analysis identifies imidazo[1,2-b]pyridazines as PIM kinase inhibitors with in vitro antileukemic activity.

University Hospital Basel

Novel cambinol analogs as sirtuin inhibitors: synthesis, biological evaluation, and rationalization of activity.

University of St. Andrews